edotreotide has been researched along with fluorodeoxyglucose f18 in 10 studies
| Studies (edotreotide) | Trials (edotreotide) | Recent Studies (post-2010) (edotreotide) | Studies (fluorodeoxyglucose f18) | Trials (fluorodeoxyglucose f18) | Recent Studies (post-2010) (fluorodeoxyglucose f18) |
|---|---|---|---|---|---|
| 206 | 34 | 86 | 34,771 | 2,160 | 20,111 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eichhorn, K; Freitag, P; Gratzl, O; Hofer, S; Maecke, R; Merlo, A; Mueller-Brand, J; Probst, A; Reubi, JC; Schumacher, T; Wasner, M; Zimmerer, S | 1 |
| Abolmaali, ND; Abramyuk, AM; Tokalov, SV; Zophel, K | 1 |
| Dutta, R; Jindal, T; Kumar, A; Kumar, R; Malhotra, A; Meena, M; Venkitaraman, B | 1 |
| Cornelissen, C; Frechen, D; Krüger, S; Kweider, S; Temur, Y | 1 |
| Balogova, S; Huchet, V; Kerrou, K; Michaud, L; Montravers, F; Nataf, V; Talbot, JN | 1 |
| Beiderwellen, K; Bellendorf, A; Bockisch, A; Gerken, G; Gomez, B; Heusch, P; Kinner, S; Langhorst, J; Lauenstein, TC; Lenga, L; Ruenzi, M; Umutlu, L | 1 |
| Buck, AK; Herrmann, K; Kropf, S; Lapa, C; Lückerath, K; Pelzer, T; Rudelius, M; Samnick, S; Schirbel, A; Schmid, JS; Schoene, A; Wester, HJ | 1 |
| Hirota, S; Kadoya, M; Koyama, H; Kurajoh, M; Miyoshi, A; Moriwaki, Y; Nakamoto, Y; Shoji, T; Terada, T; Tsukamoto, Y | 1 |
| Antoch, G; Bruckmann, NM; Herrmann, K; Ingenwerth, M; Kirchner, J; Lahner, H; Rischpler, C; Sawicki, LM; Theurer, S; Umutlu, L | 1 |
| Blau, T; Damman, P; Deuschl, C; Fendler, WP; Glas, M; Grueneisen, J; Guberina, M; Haubold, J; Kebir, S; Kessler, L; Li, Y; Milosevic, A; Morawitz, J; Schaarschmidt, BM; Styczen, H; Weber, M; Wrede, K | 1 |
1 review(s) available for edotreotide and fluorodeoxyglucose f18
| Article | Year |
|---|---|
18F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type.
Topics: 3-Iodobenzylguanidine; Bronchial Neoplasms; Carcinoma, Merkel Cell; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung Neoplasms; Multimodal Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Octreotide; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Recurrence; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon | 2013 |
1 trial(s) available for edotreotide and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Local injection of the 90Y-labelled peptidic vector DOTATOC to control gliomas of WHO grades II and III: an extended pilot study.
Topics: Adult; Aged; Brachytherapy; Brain Neoplasms; Dose-Response Relationship, Radiation; Feasibility Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Injections, Intralesional; Magnetic Resonance Imaging; Male; Middle Aged; Octreotide; Pilot Projects; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Adjuvant; Receptors, Somatostatin; Sensitivity and Specificity; Treatment Outcome; World Health Organization; Yttrium Radioisotopes | 2002 |
8 other study(ies) available for edotreotide and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Retrospective analysis of radiation load during examination of cancer patients by (68)Ga-DOTATOC and (18)F-FDG positron emission tomography.
Topics: Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gadolinium; Humans; Neoplasms; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Radiation Dosage; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2008 |
Evaluation of the role of [18F]FDG-PET/CT and [68Ga]DOTATOC-PET/CT in differentiating typical and atypical pulmonary carcinoids.
Topics: Adolescent; Adult; Carcinoid Tumor; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung Neoplasms; Middle Aged; Octreotide; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
[Neuroendocrine pulmonary neoplasms: improved diagnosis by DOTATOC- vs. FDG-PET/CT].
Topics: Biopsy; Bone Neoplasms; Carcinoma, Neuroendocrine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lumbar Vertebrae; Lung; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Octreotide; Positron-Emission Tomography; Ribs; Sacrum; Spinal Neoplasms; Tomography, X-Ray Computed | 2011 |
Hybrid imaging of the bowel using PET/MR enterography: Feasibility and first results.
Topics: Contrast Media; Feasibility Studies; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Image Enhancement; Intestinal Diseases; Intestines; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Octreotide; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
[68Ga]Pentixafor-PET/CT for imaging of chemokine receptor 4 expression in small cell lung cancer--initial experience.
Topics: Adult; Aged; Coordination Complexes; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung Neoplasms; Male; Middle Aged; Octreotide; Peptides, Cyclic; Positron Emission Tomography Computed Tomography; Receptors, CXCR4; Receptors, Somatostatin; Small Cell Lung Carcinoma | 2016 |
Ectopic adrenocorticotropic hormone syndrome associated with olfactory neuroblastoma: acquirement of adrenocorticotropic hormone expression during disease course as shown by serial immunohistochemistry examinations.
Topics: Adrenocorticotropic Hormone; Blood Glucose; Disease Progression; Eosinophils; Esthesioneuroblastoma, Olfactory; Fluorodeoxyglucose F18; Humans; Hydrocortisone; Immunohistochemistry; Leukocyte Count; Male; Metyrapone; Middle Aged; Octreotide; Positron-Emission Tomography; Potassium; Syndrome | 2018 |
Correlation between contrast enhancement, standardized uptake value (SUV), and diffusion restriction (ADC) with tumor grading in patients with therapy-naive neuroendocrine neoplasms using hybrid
Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasm Grading; Neoplasms; Octreotide; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2021 |
Correlation of the apparent diffusion coefficient with the standardized uptake value in meningioma of the skull plane using [68]Ga-DOTATOC PET/MRI.
Topics: Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Meningeal Neoplasms; Meningioma; Positron-Emission Tomography; Radiopharmaceuticals; Skull | 2023 |